Results
|
|
2401.
|
|
|
|
2402.
|
|
|
|
2403.
|
|
|
|
2404.
|
|
|
|
2405.
|
|
|
|
2406.
|
|
|
|
2407.
|
|
|
|
2408.
|
|
|
|
2409.
|
|
|
|
2410.
|
|
|
|
2411.
|
Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins alphavbeta3 and alphavbeta5 in patients with advanced solid tumours. [electronic resource] by
- Eskens, F A L M
- Dumez, H
- Hoekstra, R
- Perschl, A
- Brindley, C
- Böttcher, S
- Wynendaele, W
- Drevs, J
- Verweij, J
- van Oosterom, A T
Producer: 20030701
In:
European journal of cancer (Oxford, England : 1990) vol. 39
Availability: No items available.
|
|
|
2412.
|
|
|
|
2413.
|
|
|
|
2414.
|
|
|
|
2415.
|
|
|
|
2416.
|
|
|
|
2417.
|
|
|
|
2418.
|
|
|
|
2419.
|
|
|
|
2420.
|
|